199 related articles for article (PubMed ID: 12882913)
1. Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity.
Ma L; Qian S; Liang X; Wang L; Woodward JE; Giannoukakis N; Robbins PD; Bertera S; Trucco M; Fung JJ; Lu L
Diabetes; 2003 Aug; 52(8):1976-85. PubMed ID: 12882913
[TBL] [Abstract][Full Text] [Related]
2. Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium.
Zhang C; Zou X; Leluo G; Xu J; Xiang M
Methods Find Exp Clin Pharmacol; 2008; 30(6):421-9. PubMed ID: 18850043
[TBL] [Abstract][Full Text] [Related]
3. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
Tiao MM; Lu L; Tao R; Wang L; Fung JJ; Qian S
Ann Surg; 2005 Mar; 241(3):497-505. PubMed ID: 15729074
[TBL] [Abstract][Full Text] [Related]
4. Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function.
Poligone B; Weaver DJ; Sen P; Baldwin AS; Tisch R
J Immunol; 2002 Jan; 168(1):188-96. PubMed ID: 11751962
[TBL] [Abstract][Full Text] [Related]
5. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
6. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.
Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages.
Sen P; Bhattacharyya S; Wallet M; Wong CP; Poligone B; Sen M; Baldwin AS; Tisch R
J Immunol; 2003 Feb; 170(4):1770-80. PubMed ID: 12574341
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.
Giannoukakis N; Bonham CA; Qian S; Chen Z; Peng L; Harnaha J; Li W; Thomson AW; Fung JJ; Robbins PD; Lu L
Mol Ther; 2000 May; 1(5 Pt 1):430-7. PubMed ID: 10933964
[TBL] [Abstract][Full Text] [Related]
11. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
[TBL] [Abstract][Full Text] [Related]
12. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice.
Cao H; Lu J; Du J; Xia F; Wei S; Liu X; Liu T; Liu Y; Xiang M
Sci Rep; 2015 Oct; 5():14593. PubMed ID: 26459028
[TBL] [Abstract][Full Text] [Related]
13. Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes.
Mondanelli G; Volpi C; Bianchi R; Allegrucci M; Talesa VN; Grohmann U; Belladonna ML
Cytokine; 2015 Oct; 75(2):380-8. PubMed ID: 26003759
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.
Machen J; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
J Immunol; 2004 Oct; 173(7):4331-41. PubMed ID: 15383562
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
16. Lowered expressions of the NF-kappaB family members in dendritic cells from NOD mice are associated with a reduced expression of GATA-2.
Takahashi K; Satoh J; Oka Y
Ann N Y Acad Sci; 2008 Dec; 1150():59-60. PubMed ID: 19120268
[TBL] [Abstract][Full Text] [Related]
17. The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes.
Liang X; Ma L; Thai NL; Fung JJ; Qian S; Lu L
Immunology; 2007 Feb; 120(2):251-60. PubMed ID: 17233742
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
Pane JA; Webster NL; Zufferey C; Coulson BS
Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
[TBL] [Abstract][Full Text] [Related]
19. Augmented regeneration of partial liver allograft induced by nuclear factor-kappaB decoy oligodeoxynucleotides-modified dendritic cells.
Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
World J Gastroenterol; 2004 Feb; 10(4):573-8. PubMed ID: 14966919
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of NOD mice with bone marrow-derived dendritic cells.
Feili-Hariri M; Dong X; Alber SM; Watkins SC; Salter RD; Morel PA
Diabetes; 1999 Dec; 48(12):2300-8. PubMed ID: 10580417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
